Curriculum · Musculoskeletal / Orthopedic / Rheumatology
Systemic lupus erythematosus
What it is
Systemic lupus erythematosus is an autoimmune disorder leading to inflammation and tissue damage in multiple organ systems. It is an idiopathic chronic inflammatory disease with genetic, environmental and hormonal factors, and being systemic it can affect any part of the body.
Causes and risk
There is a genetic predisposition, with HLA-DR2 and HLA-DR3 named, and environmental and hormonal factors play a role. Women are affected far more than men and the peak age is 20-40 years. It typically affects non-Caucasian females with the age of onset in early adulthood.
How it presents
General symptoms are fever, fatigue and weight loss. The skin and the mouth give a malar or butterfly rash, discoid lupus, photosensitivity, nonscarring alopecia, oral ulcers, which are painless, and cheilitis. The joints give arthralgia, myalgia, morning stiffness and a nonerosive arthritis, that is a symmetrical small joint polyarthritis that does not erode. Serositis appears as pleuritis or pericarditis, with pleural effusion. Renal involvement is lupus nephritis, with protein in the urine or red blood cell casts. CNS involvement covers seizures, psychosis and personality changes. The blood shows thrombocytopenia, leukopenia or lymphopenia and a warm hemolytic anemia. Other features are Raynaud phenomenon, periungual telangiectasia, dry eyes as part of a sicca syndrome, esophagitis and peripheral neuropathy.
How it is diagnosed
The serology is ANA, especially anti-dsDNA, together with anti-Ro/SSA, anti-Sm and antiphospholipid antibodies; C3 and C4 complement levels fall, so the complements should never be forgotten. Diagnosis is made on the 2012 SLICC criteria: 1) at least 4 positive criteria, with at least 1 clinical and 1 immunologic criterion; 2) or biopsy proven lupus nephritis with a positive ANA or anti-dsDNA. The clinical criteria are: 1) acute cutaneous lupus, that is a maculopapular lupus rash, a malar rash or a photosensitive lupus rash; 2) chronic cutaneous lupus, that is a discoid rash or mucosal lupus; 3) oral or nasal ulcers; 4) nonscarring alopecia; 5) synovitis in more than 2 joints; 6) serositis; 7) renal disease shown by a urine protein-to-creatinine ratio representing 500 mg of protein over 24 hours or by red blood cell casts; 8) neurologic disease; 9) hemolytic anemia; 10) leukopenia or lymphopenia; 11) thrombocytopenia. The immunologic criteria are: 1) a high ANA concentration; 2) a high anti-dsDNA antibody concentration; 3) the presence of anti-Sm; 4) a positive APA; 5) low complement, C3, C4 or CH50; 6) a direct Coombs test. The lecture note beside that table says to know the immunologic features in particular, and that complement levels are low because it is a type 3 hypersensitivity. Two other sets are named beside it. The ACR 1997 criteria ask for 4 out of 11 to diagnose the patient, and sometimes even 3 is enough if the clinical suspicion is very high and ANA and anti-DNA are positive; that older list is skin, arthritis, serositis, blood, renal, CNS, immunologic and ANA. The updated ACR 2019 criteria are built in 3 steps: 1) ANA is a must; 2) then 7 clinical and 3 immunological criteria, with scoring from 2 to 10 for each; 3) a total score of 10 or more means the patient has SLE. The set our pages diagnose on is the 2012 SLICC one. Antibodies to Ro and La are the ones that result in neonatal lupus. Renal investigations must not be forgotten. A table of antibodies and their associations runs the other way round, from antibody to disease, and that is how the specific one is told from a list of options. Anti-dsDNA or anti-Smith belongs to SLE. Anti-histone belongs to drug-induced lupus, where the drug to think of is hydralazine. Anti-Ro (SSA) or anti-La (SSB) belongs to Sjogren's syndrome. Anti-centromere belongs to CREST syndrome. Anti-Scl 70, that is anti-topoisomerase, belongs to systemic sclerosis. Anti-RNP belongs to mixed connective tissue disease. Rheumatoid factor, which is against the Fc of IgG, together with anti-CCP, belongs to rheumatoid arthritis. The investigations are ordered: 1) screening with ANA; 2) confirmation with anti-ENA and anti-dsDNA.